Singapore markets open in 1 hour 32 minutes

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
460.98+6.75 (+1.49%)
At close: 4:00PM EST

461.04 +0.06 (0.01%)
After hours: 5:28PM EST

Currency in USD

Valuation measures

Market cap (intra-day) 539.32B
Enterprise value 339.56B
Trailing P/E 80.37
Forward P/E 168.50
PEG Ratio (5 yr expected) 14.34
Price/sales (ttm)15.18
Price/book (mrq)89.25
Enterprise value/revenue 315.27
Enterprise value/EBITDA 654.01

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 380.75%
S&P500 52-week change 316.84%
52-week high 3485.00
52-week low 3168.65
50-day moving average 3440.94
200-day moving average 3374.00

Share statistics

Avg vol (3-month) 3422.54k
Avg vol (10-day) 3371.86k
Shares outstanding 585.3M
Float 84.37M
% held by insiders 11.09%
% held by institutions 188.44%
Shares short (12 Nov 2020) 41.03M
Short ratio (12 Nov 2020) 42.36
Short % of float (12 Nov 2020) 41.38%
Short % of shares outstanding (12 Nov 2020) 41.21%
Shares short (prior month 14 Oct 2020) 41.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Sep 2020


Profit margin 19.20%
Operating margin (ttm)24.64%

Management effectiveness

Return on assets (ttm)21.01%
Return on equity (ttm)154.61%

Income statement

Revenue (ttm)2.59B
Revenue per share (ttm)30.33
Quarterly revenue growth (yoy)19.20%
Gross profit (ttm)1.37B
EBITDA 732.49M
Net income avi to common (ttm)497.48M
Diluted EPS (ttm)5.74
Quarterly earnings growth (yoy)34.30%

Balance sheet

Total cash (mrq)175.59M
Total cash per share (mrq)2.06
Total debt (mrq)990.6M
Total debt/equity (mrq)224.57
Current ratio (mrq)1.65
Book value per share (mrq)5.16

Cash flow statement

Operating cash flow (ttm)584.54M
Levered free cash flow (ttm)357.18M